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Abstract
Wholegrain oats are known to modulate the human gut microbiota and have prebiotic properties (increase the growth of some health-
promoting bacterial genera within the colon). Research to date mainly attributes these effects to the fibre content; however, oat is also a rich
dietary source of polyphenols, which may contribute to the positive modulation of gut microbiota. In vitro anaerobic batch-culture
experiments were performed over 24 h to evaluate the impact of two different doses (1 and 3% (w/v)) of oat bran, matched concentrations of
β-glucan extract or polyphenol mix, on the human faecal microbiota composition using 16S RNA gene sequencing and SCFA analysis.
Supplementation with oats increased the abundance of Proteobacteria (P< 0·01) at 10 h, Bacteroidetes (P< 0·05) at 24 h and concentrations of
acetic and propionic acid increased at 10 and 24 h compared with the NC. Fermentation of the 1% (w/v) oat bran resulted in significant
increase in SCFA production at 24 h (86 (SD 27) v. 28 (SD 5)mM; P< 0·05) and a bifidogenic effect, increasing the relative abundance of
Bifidobacterium unassigned at 10 h and Bifidobacterium adolescentis (P< 0·05) at 10 and 24 h compared with NC. Considering the β-glucan
treatment induced an increase in the phylum Bacteroidetes at 24 h, it explains the Bacteriodetes effects of oats as a food matrix. The
polyphenol mix induced an increase in Enterobacteriaceae family at 24 h. In conclusion, in this study, we found that oats increased
bifidobacteria, acetic acid and propionic acid, and this is mediated by the synergy of all oat compounds within the complex food matrix, rather
than its main bioactive β-glucan or polyphenols. Thus, oats as a whole food led to the greatest impact on the microbiota.
Key words: Oats: Polyphenols: β-Glucan: Gut microbiota: 16S rRNA gene sequencing: SCFA: Bifidogenic effects
A large body of evidence from prospective and intervention
studies suggests that a diet rich in oats could significantly reduce the
risk of bowel disease(1,2) and CVD(3–5) and lowers high blood
cholesterol levels(4–7). Recent reports suggest that oats may act as a
prebiotic, modulating the gut microbiota (GM) and impacting on
metabolic disease risk(8,9). To date, it is believed that the protective
effect of whole grain oats is mainly due to the presence of dietary
fibre, in particular, soluble β-glucan(6,10–12) and resistant starch(13).
β-Glucan is known to lower cholesterol and bile acid absorption
through formation of viscous gels in the upper gut(14) and/or
directly binding of cholesterol or bile acids. Resistant starch leads to
the production of SCFA in the colon and may also increase the
growth of some health-promoting bacterial genera within, such as
Bifidobacterium and Lactobacillus(15–18). Species of these genera
influence the cholesterol metabolism through increasing bile-salt
hydrolase enzyme activity and the deconjugation of bile acids(19).
Oats, however, are also rich dietary sources of polyphenols,
including avenanthramides and phenolic acids(20). These are
likely to contribute to the health effects of a diet rich in
oats(21–23) but have not yet been examined in detail. Phenolic
acids are found in three different forms within the oat food
matrix: as soluble free acids, as soluble conjugates esterified to
low-molecular-weight components such as sugars and as
insoluble-bound acids esterified to high-molecular-weight
components including lignin, cell wall polysaccharides and
storage proteins(20). A large proportion of oat polyphenols are
bound via an ester bond, hence are poorly absorbed in the
upper intestine and reach the colon(24), where they may
beneficially modulate the microbiota(8). There are no esterases
in human tissues that break these ester links(25); therefore, the
main catalytic site is in the colon through cinnamoyl esterase
activity of human faecal microbiota, such as Escherichia coli
Abbreviations: BG, β-glucan extract; GM, gut microbiota; NC, negative control; OAT1·5, 1·5 g digested oat bran; OAT4·5, 4·5 g digested oat bran; OTU,
operational taxonomic unit; PC, positive control; POLY, polyphenol mix.
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(three isolates), Bifidobacterium lactis and Lactobacillus gasseri
(two strains)(26,27).
Gut microbiota (GM) alterations by whole grain oats have
been observed in a number of in vitro fermentation mod-
els(9,28–32) and animal studies(13,33–35). The fermentation of oats
has led to increased Bifidobacterium, Lactobacillus(8,9,30,31,33,34)
and Bacteroides(32) populations and, at the same time
decreased Clostridium(30,33).
The soluble β-glucans have been one of the most commonly
studied components of oats(28,36,37). However, oat-derived iso-
lated β-glucan only impacted on Bacteroides growth, not on
Bifidobacterium in 24 h pH-controlled anaerobic batch culture
fermenters(28). Furthermore, Crittenden et al.(38) reported that
β-glucan was fermented by Bacteroides spp. but not by Lacto-
bacillus or Bifidobacterium. The viscosity and molecular
weight of β-glucan may strongly influence its ability to lead to
SCFA production and act as a prebiotic(39). In addition, these
studies have used the relatively high concentrations of 1% v/w
of β-glucans dose(31,40) which is much higher than the physio-
logical β-glucans concentration delivered from eating oats. To
date, none of the oat or β-glucan in vitro fermentation studies
assessed the polyphenol content of their treatment(9,28,32). Thus,
little information exists on the ability of oat-derived avenan-
thramides, hydroxycinnamic and hydroxybenzoic acids to
influence the GM.
The main purpose of the present in vitro study was to
examine whether a physiologically relevant dose of polyphenol
mix (avenanthramide, hydroxycinnamic acids and benzoic acid
derivatives), β-glucan extract (BG) or digested oat bran as
whole food matrix beneficially modulates the GM. Second, the
study aimed to assess the impact of different doses of digested
oat bran on the GM, notably using an oat bran that was well
characterised in terms of physicochemical properties.
Methods
Reagents
All chemicals and reagents were purchased from Sigma-Aldrich
Chemical Co Ltd or Fisher unless stated otherwise. Mixed-linkage
β-glucan kit was supplied by Megazyme Co. The anaerobic jar
(Anaerojar™ 2·5 L) and gas-generating kit (AnaeroGen™) were
obtained from Oxoid Ltd, the dialysis tube from Spectrum (VWR
International). Media and instruments were autoclaved at 121°C
for 15min. HPLC column and guard cartridges were obtained
from Phenomenex. PowerSoil® DNA Isolation Kit was purchased
from Mo Bio Laboratories Inc., the primers for the 16S rRNA gene
amplification from Integrated DNA Technologies, BVBA, Accu-
Prime™ SuperMix II from Life Technologies, AMPure XP beads
from Beckman Coulter Genomic.
Oats and controls
The oat bran was purchased from White’s. The oat macro-
nutrient composition was analysed by Campden BRI Labora-
tories (total carbohydrate, available carbohydrate, total dietary
fibre – AOAC 991.43 method, total fat – BS 4401 and protein –
AOAC 981.10 method), whereas the detailed polyphenol
content was measured in our laboratory at the University of
Reading based on a previous method(41). The β-glucan method
used was employed specifically to quantify 1,3:1,4-β-D-glucan.
Synergy 1 the oligofructose-enriched inulin was supplied by
Beneo and 94%-BG from Megazyme Co. Polyphenols were
purchased from Sigma-Aldrich Chemical Co Ltd.
In vitro digestion of oat bran (from mouth to small
intestine)
The method employed was adapted from Mills et al.(42). Oat
bran was digested in vitro in three phases: the oral phase, the
gastric phase and the small intestinal phase. A total of 60 g of oat
bran was mixed with 150ml of sterile and distilled water and
homogenised, transferred into a 500ml Duran bottle and
microwaved for 1min. In the oral phase, 20mg of α-amylase
was dissolved in 6·25ml CaCl2 (1mM, pH 7·0) and added to the
solution, then incubated at 37°C for 30min on a shaker set at
120 g. After incubation, the pH was adjusted to 2·0 with 6 M HCl
solution and the gastric phase introduced by adding 2·7 g
pepsin in 25ml HCl (0·1 M) and further incubated for 2 h under
the same conditions. In the small intestinal phase, 560mg
pancreatin and 3·5 g bile were mixed with 125ml NaHCO3
(0·5 M) and dispensed into the mix. The pH was adjusted to 7·0
then incubated for 3 h at 37°C with shaking. Finally, the sample
solution was transferred to a seamless semi-permeable 100–500
Dalton molecular weight cut-off regenerated cellulose dialysis
tubing and dialysed against NaCl (0·01 M at 5°C) to remove low-
molecular-mass digestion products. After 15 h, the dialysis fluid
was changed and the process continued for an additional 2 h.
The digested oat bran mix was collected and transferred into
several 250ml clear plastic containers, frozen to –80°C and
freeze-dried for 5 d to remove all fluid content.
Extraction and analyses of polyphenols from undigested
and digested oat bran
Polyphenols were extracted from undigested (raw) and diges-
ted (after in vitro digestion) oat bran in two separate fractions
(i.e. free and conjugated or bound) using the method of Schar
et al.(41) The phenolic acids and avenanthramides in oat extracts
were identified and quantified using a HPLC Agilent 1100 series
(Agilent Technologies Ltd) equipped with a quaternary pump,
autosampler, column thermostat, sample thermostat and photo
diode array detector. Compound separation was achieved by a
Kinetex biphenyl column (100A 250× 4·6mm length, 5 µM
particle size; Phenomenex) and using a gradient elution. Mobile
phase A consisted of 0·1% (v/v) formic acid in HPLC water (A),
while mobile phase B was 0·1% (v/v) formic acid in methanol.
The following optimised gradient protocol was run as follows:
0min, 95% A, 5% B; 20min, 75% A, 25% B; 25min, 74% A,
26% B; 30min, 65% A, 35% B; 40min, 64% A, 36% B; 53min,
30% A, 70% B; 56min, 5% A, 95% B; 61min, 5% A, 95% B;
62min, 95% A, 5% B; 65min, 95% A, 5% B. The flow rate of
the mobile phase was 1·0ml/min and the sample injection
volume was 20 µl(43). The absorbance was recorded at 254, 280
and 320 nm and quantification was based on 12-point linear
calibration curves (mean R2> 0·99) and as a ratio to the internal
550 A. Kristek et al.
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standard (i.e. 3,5-dichloro-4-hydroxybenzoic acid) to account
for losses during extraction (R2≥ 0·99).
Determination of the β-glucan content
The β-glucan content was analysed with the 1,3:1,4 mixed-
linkage β-glucan kit. The assay uses lichenase and β-glucosidase
to metabolise β-glucan to β-gluco-oligosaccharides and subse-
quently glucose. Glucose then reacts with GOPOD (glucose
oxidase/peroxidase) reagent and its absorbance was measured at
510nm by UltroSpec 1100 photo spectrometer (Scinteck Instru-
ments LLC). The final β-glucan content was calculated by the
Megazyme Mega-Calc™ tool(44).
The molecular weight of the β-glucan was determined by
size-exclusion HPLC. The chromatography system consisted of
three serially connected columns (Shodex SB-G, Shodex
SB-806M, Shodex SB-804 HQ) and an UV-MALLS-Viscometer-
dRI detector. The column temperature was set at 40°C, the
mobile phase was MiliQ water (Millipore) containing 0·02%
sodium azide, and the flow rate set at 0·5ml/min. Samples were
prepared at a concentration of 10mg/ml, heated at 60°C for 3 h
under constant shaking, syringe filtered (0·45 µm poly-
vinylidene difluoride membrane; Whatman) and diluted to a
concentration of 1mg/ml before injection.
pH controlled faecal batch culture fermentation
Substrate ability to modulate GM was determined using anae-
robic, stirred, pH- and temperature-controlled faecal batch
cultures. Batch culture fermentation vessels (300ml volume:
one vessel per treatment) were sterilised and filled with 135ml
of sterile basal medium (g/l: 2 g peptone, 2 g yeast extract, 0·1 g
NaCl, 0·04 g K2HPO4, 0·04 g KH2PO4, 0·01 g MgSO4.7H2O,
0·01 g CaCl2.6H2O, 2 g NaHCO3, 2ml Tween 80, 0·05 g hemin
(dissolved in a few drops of 1 M NaOH), 10 µl vitamin K, 0·5 g
L-cysteine HCl, 0·5 g bile salts and 4ml of resazurin solution
(0·02%)). Before addition to the vessel, the medium was
adjusted to pH 7·0 and autoclaved. The sterile medium was
gassed overnight with O2-free N2 (15ml/min) to establish the
anaerobic conditions. To mimic the proximal region of the
human large intestine, pH was held in the range of 6·7–6·9 by
automatic addition of 0·5 M NaOH or 0·5 M HCl and controlled
via pH metre controllers (Electrolab) and the temperature was
kept at 37°C. Faecal samples were collected from three healthy
female donors, who were between 25 and 40 years of age, with
no history of bowel disorders, who had not received antibiotic
treatment for at least 6 months before the study and who had
not consumed pre- or probiotic supplements 1 month before
the study. All donors were informed of the study aims and
procedures and provided their verbal consent for stool samples
to be used for the experiments in compliance with the ethics
procedures required at the University of Reading. Samples were
collected in anaerobic jars and used within 1 h of collection.
Samples were diluted 1:10 (w/v) with anaerobic phosphate
buffer (0·1 M, pH 7·4) and homogenised in a stomacher for
2min; the batch culture systems were inoculated with 15ml
faecal slurry from an individual sample. The vessels were
treated with the following substrates: 1% (w/v), 1·5 g digested
oat bran (OAT1·5); 3% (w/v), 4·5 g digested oat bran
(digestibility of oats see McCance et al.(45)) (OAT4·5); 0·12%
(w/v), 180mg 94% BG; 0·01% (w/v), 1·7mg polyphenol mix
(same profile as 4·5 g digested oats) (POLY); 1% (w/v), 1·5 g
Synergy 1 (positive control, PC); an additional vessel was pre-
pared under the same conditions but without any substrate,
which served as the negative control (NC) (Table 2). The
Synergy 1 is an inulin enriched with oligofructose, which has
been proved for its prebiotic effects(46). The 3% (w/v) oat was
chosen as the highest dose, since it would be the concentration
reached by an average person consuming 60 g oat bran (i.e.
assuming 30 g oat bran reaches the colon and colonic total
volume is 1 litre)(45). Based on this calculation, BG and poly-
phenol mix treatments were matched to the dose present in 3%
(w/v) oat bran. Treatment with OAT1·5 was added to the
experiment tomonitor the impact of the oat dose on the prebiotic
effect. In all, 5ml sampleswere collected at 0, 5, 10, 24 h, ofwhich
1ml aliquots were centrifuged at 13 000 g for 10min. Super-
natants and pellets were stored separately at –20°C until analysis.
High-throughput sequencing of the gut microbiota
The GM compositions and dynamics were determined using
tag-encoded 16S rRNA gene MiSeq-based (Illumina) high-
throughput sequencing. DNA was extracted from 2ml of
faecal samples from fermentation vessel using power soil DNA
isolation kit. The bead-beating was performed in three cycles of
15 s each at 6·5 pulse/s (the FastPrep-24™ 5G Instrument; MP
Biomedicals). DNA concentrations and purity were determined
using Nanodrop 1000 (ThermoScientific). The V3 region of the
16S rRNA gene was amplified using primers compatible with the
Nextera Index Kit NXt_338_F: 5'-TCGTCGGCAGCGTCAGATG
TGTATAAGAGACAGACWCCTACGGGWGGCAGCAG-3' and NXt_
518_R: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAT
TACCGCGGCTGCTGG-3'(47). PCR and library preparation were
conducted as described in Kristensen et al.(48). Briefly, PCR
containing 12 µl AccuPrime SuperMix II, 0·5 µl of each primer
(10 µM), 5 µl of genomic DNA (approximately 10ng/µl) and
nuclease-free water to a total volume of 20 µl were run on a
SureCycler 8800 (Agilent). Applied cycling conditions were as
follows: denaturation at 95°C for 2min; thirty-five cycles of 95°C
for 15 s, 55°C for 15 s and 68°C for 40 s; followed by final elon-
gation at 68°C for 5min. To incorporate primers with adapters
and indices, PCR contained 12 µl Phusion High-Fidelity PCR
Master Mix, 2 µl P5 and P7 primer, 2 µl PCR product and
nuclease-free water for a total volume of 25µl.
Cycling conditions applied were as follows: 98°C for 1min;
twelve cycles of 98°C for 10 s, 55°C for 20 s and 72°C for 20 s;
elongation at 72°C for 5min. The amplified fragments with
adapters and tags were purified using AMPure XP beads. Before
library pooling, clean constructs were quantified using a Qubit
fluorometer (Invitrogen) and mixed in approximately equal
concentrations to ensure even representation of reads per
sample; 180bp pair-ended MiSeq (Illumina) sequencing was then
performed according to the instructions of the manufacturer. The
raw data set containing pair-ended reads with corresponding quality
scores was trimmed using CLC Genomic Workbench (CLC bio).
Trimming settings were set to a low-quality limit of 0·01, with no
ambiguous nucleotides allowed, and trimming off the primer
Effect of oats on the human gut microbiota 551
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sequences. Merging overlapped reads was performed using the
‘Merge overlapping pairs’ tool by default settings. The Quantitative
Insight Into Microbial Ecology (QIIME) tool (version 1.8.0; Open
Source Software) was used for further analysis(49).
Purging the data set from chimeric reads was performed using
USEARCH, while the usearch61 method was used for operational
taxonomic units (OTU) selection(50). The Greengenes (version
12.10) 16S rRNA gene database and EzTaxon were used as
reference(51,52).
High-throughput sequencing yielded 12 465 219 sequences
free from chimeric reads, providing an average of 178 202
(SD 80 036) sequences per sample (range 292–447 040), five
baseline samples and one 10 h sample were excluded due to
low reads (292–509).
SCFA analysis
The defrosted supernatant samples were filtered (0·22µm; Milli-
pore) and spiked with 50µl internal standard (2-ethyl butyric acid,
100mM). SCFA were measured in an ion exclusion HPLC system
(Agilent 1100 Series) equipped with a diode array detector
(G-1315B), autosampler (G1316A) and Aminex HPX-8711 column
(300×7·8mm) heated to 84°C. Samples (20µl) were injected in
duplicate, and UV absorption was measured at 214nm. The mobile
phase was 2·5mM aqueous sulphuric acid run at a flow rate of
0·6ml/min. Peaks were integrated using Agilent ChemStation soft-
ware (Agilent Technologies) and single-point internal standard
method. Peak identity and quantification were determined using a
mixture of standards of acetic, butyric, iso-butyric, propionic, lactic,
formic, valeric and isovaleric acids. Quantification was based on the
10-point calibration curve of analytical standards (R2≥0·99).
Statistics
For calculation of α and β diversity measurement of the
sequencing data, the d and e values were set to 9800 reads/
sample (85% of the sequence number of the most indigent
sample). α-Diversity measures expressed with an observed
species, Chao1, the sequence similarity 97% OTU value were
computed for rarefied OTU tables using the α rarefaction
workflow. Differences in α diversity were determined using a
t test-based approach employing the non-parametric (Monte
Carlo) method (999 permutations) implemented in the compare
α diversity workflow with QIIME.
The relative distribution of the genera registered was calculated
and summarised at the genus level OTU tables, followed by
principal coordinates analysis (PCoA) plots generated with the
Jackknifed β diversity workflow based on ten distance matrices
calculated using ten subsampled OTU tables with QIIME. The P
value and the conservative false discovery rate (FDR)-corrected P
value for multiple comparisons are reported. Three-dimensional
plots were constructed using the three primary PC from the PCoA
of the MiSeq analysis to visualise group differences in the GM
composition.
For the rest of the data analysis, GraphPad Prism statistics
software package version 7 was used. One-way ANOVA was
used to determine the differences between fermentation treat-
ments (OAT1·5, OAT4·5, POLY, BG) at the same time point
(0, 5, 10 or 24 h), followed by the least significant difference
(Bonferroni) post hoc test. A repeated-measures ANOVA was
used to explore the differences within the same treatment
(OAT1·5, OAT4·5, POLY, BG) with all the time points (0, 5, 10
and 24 h) with Bonferroni as the post hoc test. In addition to
these analyses, the P values were corrected using FDR, and
P≤ 0·05 was considered statistically significant.
Results
The composition of undigested and digested oat bran
The macronutrient, fibre and phenolic content of undigested
and digested oat bran are reported in Table 1. The in vitro oral,
gastric and small intestine digestion reduced the carbohydrate
content by 53%, available carbohydrate by 62%, while the
dietary fibre and β-glucan content remained stable, losing only
2 and 12%, respectively. Free and conjugated, bound poly-
phenol compounds decreased by 48 and 26%, respectively.
Polyphenols and β-glucan content in oat bran and extract
The OAT4·5 contained 1·73mg polyphenols (total amount of
free + conjugated and bound), the POLY intervention were
Table 1. Macronutrient, fibre and phenolic content of oat bran before and
after in vitro digestion and bioaccessibility (%) through digestion*
Components
Before
digestion
After
digestion
Bioaccessibility
(%)
Amount (g) 60 40 33
Total carbohydrate (g) 37·8 17·6 53
Available carbohydrate (g) 32·6 12·5 62
Total dietary fibre (g) 5·2 5·1 2
β-Glucan (g) 1·7 1·5 12
Total protein (g) 7 5 29
Fat (g) 3 1·1 63
Free + conjugated
polyphenols
6·2 3·2 48
Hydroxybenzoic acids (mg) 1·2 1·1 8
Hydrocinnamic acids (mg) 4·6 2·1 54
Avenanthramides (mg) 0·4 0·1 75
Bound polyphenols 16·4 12·2 26
Hydroxybenzoic acids (mg) 1 0·4 60
Hydrocinnamic acids (mg) 15·4 11·8 23
Avenanthramides (mg) ND ND –
Total polyphenols (mg) 22·6 15·4 32
ND, not detected.
* Bioaccessibility – evaluated following in vitro upper gut digestion procedures, we
have used the term bioavailability to indicate the percentage of compound
remaining, thus available to the large gut microbiota. This term was first defined by
Dall’Asta et al.(42).
Table 2. In vitro fermentation treatments
Treatment β-Glucan (mg) Polyphenol (mg)
OAT1·5 56·67 0·58
OAT4·5 170 1·73
BG (94% of extract) 180 0·1
POLY ND 1·73
PC ND ND
NC ND ND
OAT1·5, 1·5 g digested oat bran; OAT4·5, 4·5 g digested oat bran; BG, β-glucan
extract; POLY, polyphenol mix; ND, not detected; PC, positive control; NC, negative
control.
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matched to OAT4·5 (Table 2). OAT1·5 and OAT4·5 delivered
56·67 and 170mg β-glucan, respectively; the BG vessel to match
OAT4·5 180mg of 94% BG was added (Table 2). The molecular
weight of the β-glucan in the digested oat bran and the extract
was similar (335·5 (SD 1·0) and 387·3 (SD 1·0) kDa; P> 0·05).
Changes in α- and β-diversity
Independent of the donor, α-diversity decreased with oat treat-
ments over the 24h fermentation period (Chao1 2618 (SD 15) at
0 h v. 1577 (SD 22) at 24h for OAT1·5) but was constant over time
in the NC (Chao1 2639 (SD 87) at 0 h v. 2488 (SD 77) at 24 h) and
POLY (Chao1 2655 (SD 138) at 0 h v. 2241 (SD 320) at 24 h).
PCoA analyses based on unweighted UniFrac distance
matrices of all samples showed a clear donor effect (Fig. 1(a)).
However, the donor effect was no longer significant when using
weighted UniFrac distance matrix analysis (analysis of similarity
test, donor 1 v. donor 2 P= 1, donor 1 v. donor 3 P = 1, donor 2
v. donor 3 P= 1, Fig. 1(b)).
Across all samples, seven bacterial phyla were classified and
one phylum designated as unassigned. Phyla composition was
similar for all donors (P< 0·06), although at baseline the third
donor had lower Tenericutes (P< 0·01), while the second donor
had higher Actinobacteria (P< 0·05). At baseline, the bacterial
communities were dominated by Firmicutes (57–67%) and
Bacteroidetes (32–41%), while the remaining five phyla
including Actinobacteria (0·8–1·4%), Verrucomicrobia,
Cyanobacteria, Tenericutes and Proteobacteria (0·4–0·9%)
constituting <1·5% of the community (Fig. 2).
Compositional shifts
Supplementation with OAT4·5 led to a lower abundance of
Firmicutes (P< 0·02) at 5–24 h and to an increased abundance
of Proteobacteria (P< 0·01) and Bacteroidetes at 24 h compared
with NC. A similar trend was observed for OAT1·5 (P values)
(Fig. 2).
The OAT1·5 treatment had a significant effect on the relative
abundance of Actinobacteria at 10 h. The relative abundance of
Actinobacteria differed between OAT1·5 and OAT4·5 at base-
line (1·1 and 0·8%, respectively). Following 10 h fermentation,
Actinobacteria were almost four times higher in OAT1·5 com-
pared with OAT4·5 (4·9 and 1·3%, respectively), however, dif-
ferences did not persist over 24 h (4·2 v. 3·4%, respectively).
The treatment of BG and POLY did not promote the growth of
Actinobacteria, even though their dose was matched to the
OAT4·5 treatment. The PC, Synergy 1, resulted in the strongest
bifidogenic effect and the relative abundance of Actinobacteria
(baseline 1·1% v. 5 h at 31·1%, 10 h at 11·5%, P< 0·05) (Fig. 2).
Focusing on changes over 24 h, the abundance of Bacterio-
detes increased with BG (49·3% v. NC for 21%), whereas
Proteobacteria significantly decreased in comparison with the
NC (14 v. 33·5%). In POLY treatment, the abundance of Pro-
teobacteria increased over the course of fermentation (45% v.
NC for 33·5%) and decreased for Bacteriodetes (P< 0·04) (18·6
v. 46·8% for OAT4·5). The oats and BG treatments promoted
the growth of Bacteriodetes (Fig. 2).
At the lower taxonomic level and across all samples, fifty-
nine genera and sixty-nine species were identified when setting
the cut-off at a relative abundance above 0·1% of the com-
munity (Table 3). At 5 h, the OAT4·5 treatment led to a sig-
nificantly lower abundance of Ruminococcus (0·1%) and
Coprococcus (0·1%) genus and, at the same time, increased the
proportion of unassigned Enterobacteriaceae (61·2%) com-
pared with NC (25·8%) (Table 3). Most notably, OAT1·5
increased the abundance of Bifidobacterium unassigned (1·5 v.
0·2% for NC, P< 0·05) at 10 h and Bifidobacterium adolescentis
at 10 h (1·9 v. 0·3% for NC, P< 0·04) and at 24 h (2 v. 0·4% for
NC, P< 0·02) (Table 3), whereas OAT4·5 did not significantly
PC2 (15.58 %)
PC1 (15.71 %)
PC3 (10.72 %)
PC2 (20.29 %)
PC1 (32.78 %)
PC3 (11.08 %)
(a)
(b)
Fig. 1. Principal coordinates analysis (PCoA) plots of 16S rRNA gene profiles
based on (a) unweighted and (b) weighted phylogenetic Unifrac distance
matrices calculated from ten rarefied operational taxonomic unit tables (9800
reads/samples); unweighted (a) showing clear clustering according to donors
(analysis of similarity (ANOSIM) test, P= 0·01). The degree of variation
between ten jackknifed replicates of PCoA is displayed with confidence
ellipsoids around each sample. Weighted (b) quantitative information used to
generate the bacterial relative abundance of donors showed no clear clustering
(ANOSIM test, P> 0·05) for a whole dataset (24 h in vitro batch culture
fermentation inoculated with three healthy donors faeces and administered with
digested oat bran 1·5g (OAT1·5) and 4·5 g (OAT4·5), β-glucan extract (BG),
polyphenol mix (POLY), Synergy 1 (positive control (PC)) and negative control
(NC) as the substrates). , Donor 1; , donor 2; , donor 3.
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impact the relative abundance of these species due to the high
standard deviation among donors. Using EzTaxon database, we
were able to further identify the species designation of several
OTU at 24 h with BG and POLY treatments. At 24 h, the BG
treatment had higher abundances in Bacteroides ovatus
(13·5%), Bacteroides uniformis (12·9%) and Bacteroides xyla-
niosolvens (3·7%) species, while POLY led to the most abun-
dant levels of Enterobacteriaceae species, Hafnia alvei (21·7%).
However, these changes mediated by BG and POLY treatments
were not significantly different compared with NC.
Production of SCFA
OAT4·5 led to a high production of total SCFA compared with
NC at 10 h (98·2 (SD 22) v. 12·8 (SD 4)mM, respectively) and 24 h
(151·5 (SD 43) v. 28·1 (SD 5)mM). The concentration of butyric
acid was significantly increased after 24 h fermentation of
OAT1·5 (P< 0·05), and PC at 10 h (P< 0·05) and 24 h (P< 0·01)
compared with NC (Fig. 3). Acetic acid was the most abundant
SCFA. Both oat treatments resulted in a significant increase in
acetic acid at 10 h (P< 0·01), and 24 h (P< 0·01) compared with
baseline and NC (Fig. 3). At 24 h, OAT4·5, OAT1·5 and PC
significantly increased the concentration of propionic acid
compared with NC (48 (SD 24), 16·7 (SD 3), 21 (SD 9) and 4·5
(SD 0·3)mM, respectively, P< 0·01, 0·05 and 0·05, respectively).
Lactic and formic acids increased upon fermentation of OAT4·5
after 10 h compared with baseline but did not reach significance
due to the large variation among donors. BG led to a small
production of acetic and butyric acids (not significant), whereas
POLY did not induce SCFA production. Overall, there was a
dose–response effect between the two oats doses in total SCFA
at 10 h (98·2 (SD 22) v. 58 (SD 19)mM, respectively, P< 0·05) and
24 h (151·5 (SD 43) v. 86·1 (SD 27)mM, P< 0·05).
Discussion
This study aimed to identify the impact of different doses of oats
and its isolated bioactive compounds (i.e. β-glucan or poly-
phenols) on the faecal GM using in vitro systems. Digested oat
bran decreased α diversity and had a bifidogenic effect but
isolated β-glucan or polyphenol mix given at a matched dose
did not induce a similar effect (Fig. 2). This is likely to be
because these compounds alone did not provide enough
energy for bacterial growth. We have demonstrated that OAT1·5
significantly increased the proliferation of B. adolescentis
(Table 3). An increase in Bifidobacterium (genus level) was
reported by Connolly et al.(9) and Kedia et al.(30) after
fermentation of 1 and 5% oat grains in similar in vitro studies.
B. adolescentis has a number of benefits including prevention
of the development of diabetes by stimulating insulin secretion.
Furthermore, B. adolescentis has the ability to synthesise and
secrete the neuroactive substance γ-aminobutyric acid (GABA).
GABA facilitates communication between bacteria and the
human nervous system, enabling release of other neuro-
transmitters from specific epithelial intestinal cells(53,54). Our
main findings suggest that oat bran could have beneficial effects
on the host through increasing the relative abundance of
B. adolescentis.
In accordance with the literature(55,56), the compositional
analysis of digested oat bran showed limited degradation of
β-glucan in the stomach and the small intestine (Table 1). BG
(180mg – 387 kDa) did not introduce changes to Actinobacteria
0 20 40 60 80 100
Relative abundance %
0 h
OAT4.5
0 h
0 h
0 h
5 h
5 h
5 h
5 h
10 h
10 h
10 h
10 h
24 h
24 h
24 h
24 h
POLY
BG
OAT1.5
NC
PC
0 h
0 h
24 h
24 h
10 h
10 h
5 h
5 h
Fig. 2. Changes in bacterial phyla (relative abundances (%)) 0, 5, 10 and 24 h in vitro batch culture fermentation. This experiment was conducted three times, with a
different faecal donor used for each run. The media was supplemented with digested oat bran 1·5g (OAT1·5) and 4·5 g (OAT4·5), β-glucan extract (BG), polyphenol mix
(POLY), Synergy 1 (positive control (PC)) and negative control (NC). Samples were analysed at 0, 5, 10, 24 h. Values are means (%). , Firmicutes; , Bacteroidetes;
, Actinobacteria; , Proteobacteria and , other (<1%)
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Table 3. Significant changes (false discovery rate (FDR) P< 0·05) in relative abundance (%) of bacterial taxa at 5, 10 and 24 h of in vitro batch culture fermentation inoculated with faeces and administered
with digested oat bran 1·5 g (OAT1·5) and 4·5 g (OAT4·5), β-glucan extract (BG), polyphenol mix (POLY), Synergy 1 (positive control (PC)) and negative control (NC) as substrates (this experiment was
conducted three times, with a different faecal donor used for each run)
(Mean values with their standard errors)
Phylum Family Genus Species Time (h)
Treatment†
OAT1·5 OAT4·5 BG POLY PC NC
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE P
Actinobacteria Bifidobacteriaceae Bifidobacterium adolescentis 5 2·73 1·9 0·82 0·7 0·31 0·1 0·38 0·1 18·48* 3·5 0·39 0·2 0·001
Firmicutes Ruminococcaceae Ruminococcus Unassigned 5 0·2* 0 0·1 0·1 0·52 0·1 0·67 0·1 0·32 0·1 0·74 0·1 0·03
Firmicutes Lachnospiraceae Coprococcus Unassigned 5 0·2* 0·1 0·12* 0 0·48 0·2 0·44 0 0·76 0·3 0·54 0 0·02
Proteobacteria Enterobacteriaceae Unassigned Unassigned 5 55·46* 8·4 61·2* 9 23 6 31·9 8·6 11·33* 3·7 25·9 11 0·05
Actinobacteria Bifidobacteriaceae Bifidobacterium Unassigned 10 1·17* 10·1 1·1 0·9 0·19 0·1 0·17 0·1 4·12* 2·1 0·27 0·1 0·03
Actinobacteria Bifidobacteriaceae Bifidobacterium adolescentis 10 1·93* 0·5 0·66 0·5 0·19 0·1 0·27 0·1 6·7* 2·6 0·26 0 0·02
Firmicutes Ruminococcaceae Unassigned Unassigned 10 4·26 5 0·05* 0 8·96 2·8 8·68 1·7 9·76 10 8·85 0·8 0·03
Firmicutes Lachnospiraceae Unassigned Unassigned 10 5·14 4 0·08* 0 10·1 2·4 8·14 5 5·11 1·2 10·1 0·2 0·03
Firmicutes Lachnospiraceae Blautia Unassigned 10 0·35* 0·1 0·02* 0 1·39 0·3 1·21 0·4 1·15 0·8 1·14 0·4 0·03
Proteobacteria Enterobacteriaceae Unassigned Unassigned 10 50·2 12·2 67·2* 14 12·75* 6 36·1 9·2 6·47* 3·7 29·2 1·4 0·02
Actinobacteria Bifidobacteriaceae Bifidobacterium adolescentis 24 2·03* 0·1 1·91 1·8 0·31 0·1 0·31 0·2 6·87 3·7 0·41 0 0·05
* Mean values were significantly different (P<0·05) to NC at the same time point.
† The difference in relative abundance of taxa between treatments within the same time points was assessed by ANOVA. The P value after correction for multiple tests (sixty-nine taxa) with the FDR method.
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specifically in the Bacteroides–Prevotella group following 24h
fermentation. However, the dose of β-glucan used by Hughes
et al. was almost three times higher in concentration compared
with what was found in 60 g oat bran (containing 0·17g β-glucan),
which would equate to the consumption of 150 g oat bran.
While human digestive enzymes cannot degrade plant cell
wall polysaccharides, gut xylanolytic bacteria (e.g. B. xylanio-
solvens, B. uniformis and B. ovatus) can, while producing SCFA
with potential health-beneficial effects(58–60). Certain strains of
B. uniformis down-regulate gene and protein expression of
pro-inflammatory cytokines, notably isoform of nitric oxide
synthase and PPAR-γ and interferon-γ, resulting in reduced
inflammatory status(61), suggesting that oat β-glucan could have
beneficial effects on human health. More powered studies
should be applied to confirm this effect.
In vitro upper gut digestion (mouth to small intestine)
reduced polyphenols in the free-conjugated, bound fractions by
48 and 26%, respectively (Table 1). This is in agreement with
the findings by Dall’Asta et al.(62) on phenolic bioaccessibility in
durum wheat aleurone fractions where caffeic and sinapic acids
appeared as the most bioaccessible (83·3 and 79·5%), while
total ferulic acid and p-coumaric acid were less bioaccessible
(29·5 and 40·7%) with in vitro digestion. Moreover, several
phenolic metabolites, including vanillic acid, 4- and 3-
hydroxyhippuric acids, sulphate conjugates of benzoic and
ferulic acids, are derived from the hepatic and microbial
metabolism of oat brans(41). Schar et al.(41) found relevant
concentrations in urinary excretion of thirty different phenolics
and amounted to a total excretion of 33·7 (SD 7·3) µmol, sug-
gesting that a high proportion of oat phenolics are bioavailable
with absorption occurring both in the small intestine and then in
the large intestine within 8 h of consumption.
In the current study, POLY did not change the abundance of
the Actinobacteria phyla, which is similar to the research con-
ducted by Gwiazdowska et al.(63), which showed that 20 µg/ml
polyphenols had an effect on Bifidobacterium after 1 h incu-
bation, but no effect at 24 h. The effects of polyphenols on
microbial composition may also be related to the fact that there
is no carbohydrate energy available for this fermentation.
Therefore, at least part of the change may also be due to utili-
sation of protein as an energy source. However, in the current
study a POLY-induced increase in Enterobacteriaceae phyla
and H. alvei species was detected(64). Several studies connected
this group with polyphenol-degrading metabolism(65,66). While
Gu et al.(67) and Hunter et al.(68) observed that Enterobacter
strains could transform ferulic acid to vanillin via the non-
oxidative decarboxylation, Kuntz et al.(69) believed that the H.
alvei significantly attenuated the expression of adhesion mole-
cules and cytokine secretion (IL-8 and IL-6), resulting in
reduced inflammation(69). The higher relative abundance of
Enterobacteriaceae phyla and H. alvei species in POLY and
digested oat bran treatments might be associated with the
metabolic activity of these microbial groups towards plant-
derived polyphenols and saccharides(70).
Previous oat fermentation studies have not shown significant
increases in the growth of Enterobacteriaceae phyla and H. alvei
species(30), most likely because the fluorescence in situ hybri-
disation method used did not target Enterobacteriaceae or allow
analysis at the species level. We have detected an increased
presence of Proteobacteria phyla (Fig. 2) in all three vessels
including NC, which might be due to the artificial conditions of
batch culture systems(71,72). Facultative anaerobic microbes are
indeed less abundant in the human colon(73), but this batch
culture model may not be able to achieve a strict anaerobic
environment, causing an increase in Proteobacteria phyla(72).
Despite in vitro enzymatic digestion (mimicking the digestion
in the upper intestine before colon fermentation), the available
carbohydrate content of the oat bran remained high (62%)
(Table 1). Wholegrain oats are a source of starch (60% of the
total DM of the oat grain), consisting of 7% rapidly digestible
starch, 22% slowly digestible and 25% resistant starch(74) all of
which contribute to the available carbohydrates. The findings of
Englyst & Cummings(75) suggest that human digestive enzymes
do not break down dietary resistant starch. Strikingly, 30%
resistant starch type 4 also led to species-level alterations in a
colon and increases in B. adolescentis(76). A previous study(40)
reported that 1% (w/v) arabinoxylan, a dietary fibre found in
wholegrain including oats, has a bifidogenic effect using a
similar 24 h batch culture fermentation in vitro model, yet oats
generally have about 3·8–13·2% of arabinoxylan(20). This, in
combination with our findings, suggests that interactions among
a wide range of dietary polysaccharides may explain the bifi-
dogenic effect of oats(77).
The current results indicate that digested oat bran treatments
increase SCFA production dose dependently, with a higher dose
inducing higher acetate and propionate production but lower
butyrate (Fig. 3). Lactic acid disappeared at 24h, possibly because
it can be further metabolised by bacteria to acetic and propionic
acids(78). Acetate and lactate are widely produced by different
bacteria; however, bifidobacteria has a distinct pathway, trans-
forming glucose to acetate and lactate(79). SCFA can create acidic
conditions in the human colon, inhibiting the growth of pathogens
and reducing harmful enzyme activities in the human intestine,
while they also act as an energy source for gut epithelial cells(80,81).
Furthermore, propionate derived from carbohydrate fermentation
is a substrate for gluconeogenesis in humans and also inhibits the
utilisation of acetate for cholesterol synthesis in the colon and
liver(82,83). Therefore, oat bran may have a beneficial impact on
human health through SCFA production.
In previous studies(84,85), differences were observed between
the activity of pure and food matrix-derived β-glucan on small
intestine digestion and lipolysis. Purified β-glucan was observed
to have less gel-forming capacity and a lesser effect on lipolysis
and cholesterol metabolism than the matrix-derived β-glucan. In
addition, dietary fibre-induced SCFA production has been
shown to interact with phenolics(86), where butyric acid
increased the ferulic acid absorption in the colon, potentially
translating to higher concentrations of ferulic acid in systemic
circulation in vivo. These findings indicate positive interactions
of fibres and polyphenols within the food matrix on cholesterol
metabolism and the bioavailability of phenolics and also high-
light the importance of considering the structure and physico-
chemical properties of foods and not just the nutrient content.
In conclusion, our study has shown that oat bran as a com-
plex food matrix beneficially increases the number of B. ado-
lescentis and the amount of SCFA production. In contrast, a
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matched dose of the isolated bioactive compounds, β-glucan
and other polyphenols did not show any effect on the abun-
dance of Actinobacteria. However, by regulating the Bacter-
oides and Enterobacteriaceae families, they may also contribute
to further health benefits.
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